USD 28099 million
Report ID:
SQMIG35I2122 |
Region:
Global |
Published Date: July, 2024
Pages:
242
|Tables:
65
|Figures:
77
Contraceptive Drugs Market size was valued at USD 29996.6 million in 2022 and is poised to grow from USD 31946.38 million in 2023 to USD 52871.12 million by 2031, growing at a CAGR of 6.50% in the forecast period (2024-2031).
Increasing incidences of sexually transmitted diseases (STDs) and a growing number of women with no demand for contraceptive drugs and devices are expected to drive market growth. According to the World Health Organization, over 1.1 billion women of reproductive age (15-49 years) globally require family planning in 2019. Approximately 842 million women use contraceptive methods for family planning, while approximately 270 million women have unfulfilled contraceptive demand. Implementation of targeted programs to prevent unplanned pregnancy and associated healthcare costs, as well as increasing user awareness, is expected to drive market growth during the forecast period. Also, the increase in the number of unwanted pregnancies is expected to contribute to the growth of the market during the forecast period.
The side effects of contraceptive drugs are a major concern that may hamper the growth of the market. Oral contraceptive drugs may cause stomach upset, bloating, dizziness, or headache. Also, injectable contraceptives have been related to side effects such as stomach bloating, weight gain, depression, and baldness. Growing infertility prevalence might hamper the industry demand during the forecast period. The lack of uniformity in sex education in developed countries is a major challenge to the growth of global contraceptive drugs market.
US Contraceptive Drugs Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 28099 million
Largest Segment
Oral contraceptive pills
Fastest Growth
Oral contraceptive pills
Growth Rate
6.5% CAGR
To get more reports on the above market click here to Buy The Report
Global contraceptive drugs market is segmented on the basis of product, distribution channel and region. On the basis of product, global market is segmented into, oral contraceptive pills, injectable contraceptives and topical contraceptives. On the basis of distribution channel, global market is segmented into, retail pharmacy, hospital pharmacy, clinics, online channel and public channel & NGOs. On the basis of region, global market is divided into North America, Europe, Asia Pacific, Latin America, and MEA.
Contraceptive Drugs Market Analysis by Product
On the basis of product, global contraceptive drugs market is segmented into, oral contraceptive pills, injectable contraceptives and topical contraceptives. The oral contraceptive pills segment accounts for the largest revenue share in the market. The introduction of various new oral contraceptive pills, as well as their subsequent approval, has significantly impacted the market expansion. Also, awareness about the use of tablets, ease of availability, affordability, and user-friendliness are expected to support the market growth.
Injectable contraceptives are currently the second most common method of birth control. Increasing the adoption of injections to prevent unwanted pregnancy, this segment is projected to grow at the highest CAGR during the forecast period. Injections are used as a birth control method once every two to three weeks, so this method is so standard among women of working age.
Contraceptive Drugs Market Analysis by Distribution Channel
On the basis of distribution channel, global contraceptive drugs market is segmented into, retail pharmacy, hospital pharmacy, clinics, online channel and public channel & NGOs. The retail pharmacy segment accounted largest revenue share in global contraceptive drugs market. This is due to the rising demand for contraceptive pills among the public as well as increasing awareness about various contraceptive drugs. Birth control pills are sold over the counter in many countries. Also, consumers are turning to retail pharmacies to get birth control pills.
The online distribution channel segment is projected to grow at the fastest CAGR during the forecast period. Increased use of over-the-counter solutions, along with numerous online discounts and offers to attract customers, has led to the massive growth of the online channel.
To get detailed analysis on other segments, Request For Free Sample Report
On the basis of region, global contraceptive drugs market is divided into North America, Europe, Asia Pacific and MEA. North America dominated global market in 2022, due to the high incidence of abortion, rising population of women within the age group of 15-44 years, and high patient awareness levels in this region. The launch of generic and low-cost drugs and devices has led to an increase in the demand for contraceptives in teenagers. The U.S. is dominating the contraceptive drugs market in North America. The increased awareness of contraceptive pills among patients is driving the growth of the market in North America.
The Asia Pacific region is the fastest growing region in the contraceptive drugs market. China and India hold the highest market share in the Asia Pacific market. The rising reimbursement policies are driving the expansion of the Asia Pacific market. Also, the growing maternity population in the Asia Pacific region is driving the demand for contraceptives. According to the United Nations Department of Economic and Social Affairs, the population in 2019 was over 163 million. More than 56% of women in this category use contraceptives. All these factors drive global contraceptive market in the Asia Pacific.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Contraceptive Drugs Market Driver
Poor and low-income populations are represented in the overall rate of unintended pregnancy worldwide. One of the primary factors contributing to this prevalence is the use of traditional methods to prevent pregnancy. Also, unsafe abortions and maternal deaths occur every year. In Latin America, teenagers under the age of 16 have a four-time increase in the risk of maternal death compared to women in their thirties. So, the use of contraceptive drugs contributes significantly to the decrease in unplanned pregnancies.
The increasing population and increase in the number of STDs have forced government agencies to adopt strict birth control measures. Many government and non-government organizations have started family planning and birth control programs. Organizations such as the reproductive health management institute, family planning foundation, department of gynaecology, and birth control association have launched public awareness programs on proper contraception.
Contraceptive Drugs Market Restraint
Long term use of birth control pills can cause side effects such as headache, bleeding, and nausea. Long-term use means using birth control pills for 10 years or more. Also, oestrogen and progesterone-based medications are associated with an increased risk of blood clots, which can lead to heart attacks. Thus, this factor is hindering the growth of the global contraceptive drugs market.
Request Free Customization of this report to help us to meet your business objectives.
Global contraceptive drugs market is highly competitive with the presence of local as well as global companies. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of global contraceptive drugs market.
Contraceptive Drugs Market Top Player's Company Profiles
Contraceptive Drugs Market Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our business information services team that collects, collates, co-relates, and analyses the data collected by means of primary exploratory research backed by the robust secondary desk research.
According to our global contraceptive drugs market analysis, according to the World Health Organization, over 1.1 billion women of reproductive age (15-49 years) globally require family planning in 2019. Approximately 842 million women use contraceptive methods for family planning, while approximately 270 million women have unfulfilled contraceptive demand. By region, North America dominated global market in 2022 with the largest revenue share of more than 32.90% and is expected to maintain its dominance during the forecast period, due to the high incidence of abortion, rising population of women within the age group of 15-44 years, and high patient awareness levels in this region. The side effects of contraceptive drugs are a major concern that may hamper the growth of the market.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 29996.6 million |
Market size value in 2031 | USD 52871.12 million |
Growth Rate | 6.50% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Million |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
Contraceptive Drugs Market Recent Developments
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Contraceptive Drugs Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Contraceptive Drugs Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Contraceptive Drugs Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Contraceptive Drugs Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35I2122
sales@skyquestt.com
USA +1 351-333-4748